Page 3 - ஜூலியா டெஉட்ஸ்ச் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜூலியா டெஉட்ஸ்ச். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜூலியா டெஉட்ஸ்ச் Today - Breaking & Trending Today

BioXcel Therapeutics Appoints June Bray to Board of Directors

BioXcel Therapeutics Appoints June Bray to Board of Directors
Former Allergan executive brings extensive global regulatory experience across multiple therapeutic areas
March 01, 2021 07:00 ET
| Source:
BioXcel Therapeutics
BioXcel Therapeutics
New Haven, Connecticut, UNITED STATES
NEW HAVEN, Conn., March 01, 2021 (GLOBE NEWSWIRE) BioXcel Therapeutics, Inc. ( BioXcel or the Company ) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced the appointment of June Bray to its Board of Directors. Ms. Bray brings over forty years of extensive U.S. and global regulatory experience in the healthcare industry and most recently served as Senior Vice President, Global Regulatory Affairs and Medical Writing at Allergan. ....

John Graziano , Julia Deutsch , Mary Coleman , June Bray , Vimal Mehta , Actavis Forest Research Institute , Company Nasdaq , Bioxcel Therapeutics Inc , Hoechst Roussel Pharmaceuticals , University Of Rhode Island , Bayer Healthcare Pharmaceuticals , Regulatory Affairs At Organon , Fairleigh Dickinson University , Berlex Laboratories Inc , Global Regulatory Affairs , Xcel Therapeutics , Senior Vice President , Medical Writing , Chief Executive Officer , Drug Approvals , Forest Research Institute , Vice President , Regulatory Affairs , Berlex Laboratories , Rhode Island , Pharmaceutical Marketing ,

BioXcel Therapeutics Appoints Javier Rodriguez as Chief Legal Officer and Corporate Secretary

BioXcel Therapeutics Appoints Javier Rodriguez as Chief Legal Officer and Corporate Secretary
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

New York , United States , John Graziano , Julia Deutsch , Javier Rodriguez , Mary Coleman , Vimal Mehta , Reckitt Benckiser , Bayer Healthcare Pharmaceuticals Inc , Company Nasdaq , Bioxcel Therapeutics Inc , Berlex Inc , University Of Michigan , Rutgers University , University Of Pennsylvania , Xcel Therapeutics , Senior Vice President , Chief Legal Officer , Corporate Secretary , Chief Executive Officer , Bayer Healthcare Pharmaceuticals , Thelen Reid , Juris Doctor , Private Securities Litigation Reform Act , Quarterly Report , புதியது யார்க் ,

BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a .
BioXcel TherapeuticsFebruary 12, 2021 GMT
NEW HAVEN, Conn., Feb. 12, 2021 (GLOBE NEWSWIRE) BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that the Company will host a virtual Key Opinion Leader (“KOL”) event on Friday, February 19, 2021 from 11:00 am ET to 2:00 pm ET. The event aims to highlight BXCL501, the Company’s investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine (“Dex”), and its potential as a treatment option for multiple neuropsychiatric conditions. ....

Tennessee Valley , United States , John Graziano , Mary Coleman , Alan Breier , Eli Lilly , Julia Deutsch , E Wesley Ely , Scott Zeller , Larry Ereshefsky , Thomasr Kosten , National Coalition On Psychiatric Emergencies , University Of California , Company Nasdaq , Iu Psychotic Disorders Program , Mental Health Research , Psychological Symptoms Of Dementia Steering Committee , Bioxcel Therapeutics Inc , American Association For Emergency Psychiatry , Va Tennessee Valley Geriatric Research , Medications Development Center , Recovery Center , Clinical Research , Yale University School Of Medicine , Education Clinical Center , Michaele Debakey Va Medical Center ,

Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors

Published: Feb 10, 2021
NEW YORK & SAN DIEGO, Feb. 10, 2021 (GLOBE NEWSWIRE) Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced the appointment of Enoch Kariuki, PharmD, to its Board of Directors. Dr. Kariuki is a highly accomplished finance executive, bringing over a decade of deep expertise in life sciences investment banking, strategic advising and business development to Zentalis.
“We are pleased to welcome Enoch to our Board of Directors, and believe his experience as a financial leader in the healthcare sector will offer invaluable perspective for our growing organization,” said Dr. Anthony Sun, Chairman and Chief Executive Officer at Zentalis Pharmaceuticals. “Over the course of his career, Enoch has played a pivotal role in follow-on offerings and multibillion-dollar mergers and a ....

New York , United States , San Diego , Julia Deutsch , Thomas Hoffmann , Anthony Sun , Enoch Kariuki , Zentalis Pharmaceuticals Inc , Zentalis Pharmaceuticals , Investment Bank , Texas Southern University , Audit Committee , Exchange Commission , Corporate Development At Synthorx , Bristol Myers Squibb , Tuck School Of Business At Dartmouth College , Chief Executive Officer , Chief Financial Officer , Senior Vice President , Corporate Development , Vice President , Leerink Partners , Postdoctoral Fellowship , Tuck School , Dartmouth College , Texas Southern ,

BioXcel Therapeutics to Present an Update from its Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

Home / Top News / BioXcel Therapeutics to Present an Update from its Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
BioXcel Therapeutics to Present an Update from its Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
NEW HAVEN, Conn., Feb. 04, 2021 (GLOBE NEWSWIRE) BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that an update from its ongoing Phase 1b/2 trial of BXCL701, the Company’s investigational, oral innate immunity activator, in aggressive forms of prostate cancer will be presented in a poster session at the virtual 2021 ASCO Genitourinary (“ASCO GU”) Cancers Symposium. ASCO GU is being held from Thursday, February 11, 2021 t ....

John Graziano , Julia Deutsch , Mary Coleman , Company Nasdaq , Bioxcel Therapeutics Inc , Bioxcel Therapeutics , Presentation Details , Prostate Cancer , Xcel Therapeutics , ஜான் கிரஜியனோ , ஜூலியா டெஉட்ஸ்ச் , மேரி கோல்மேன் , நிறுவனம் நாஸ்டாக் , ப்ரெஸெஂடேஶந் விவரங்கள் , ப்ராஸ்டேட் புற்றுநோய் , க்ஷ்செல் சிகிச்சை ,